Forecasting PARP Inhibitor Resistance in Breast Cancer Patients

April 23, 2018
Elizabeth Swisher, MD

In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in breast cancer, and the importance of understanding how resistance to these agents develops.

In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in ovarian cancer, and the importance of understanding how resistance to these agents develops.

Related Content:

AACR | Breast Cancer